Answer
Injection-site pain and redness are very common (at least 1 in 10) after Varilrix in healthy individuals studied with subcutaneous vaccination, with a trend toward higher incidence after the second dose than the first.
Sources for this answer
- VarilrixGlaxoSmithKline UK · emc · SmPC §4.8 Undesirable effects · Version 29Document updated
Sources checked